| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy
|
Rao, C.
|
|
2018
|
30 |
3 |
p. 166-177
|
artikel
|
| 2 |
A Retrospective Assessment of the Tolerability of Hypofractionated Weekly Bladder Radiotherapy in the Elderly
|
Turner, J.
|
|
2018
|
30 |
3 |
p. 197-198
|
artikel
|
| 3 |
A Review of Chemotherapy Use in Metastatic Prostate Cancer
|
Morrison, S.
|
|
2018
|
30 |
3 |
p. 194-195
|
artikel
|
| 4 |
Bone Health Assessment and Management in Patients with Prostate Cancer Receiving Systemic Therapy — a UK Oncology Centre Experience
|
Brand, D.
|
|
2018
|
30 |
3 |
p. 194
|
artikel
|
| 5 |
Can Interrogation of Tumour Characteristics Lead us to Safely Omit Adjuvant Radiotherapy in Patients with Early Breast Cancer?
|
Bhattacharya, I.S.
|
|
2018
|
30 |
3 |
p. 158-165
|
artikel
|
| 6 |
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit
|
Sundar, R.
|
|
2018
|
30 |
3 |
p. 185-191
|
artikel
|
| 7 |
Comparison of Toxicity and Efficacy Outcomes of Capecitabine/MMC and 5FU/MMC in Patients with Bladder Cancer Treated with Radical Chemoradiotherapy
|
Li, R.
|
|
2018
|
30 |
3 |
p. 197
|
artikel
|
| 8 |
Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres
|
Sanganalmath, P.
|
|
2018
|
30 |
3 |
p. 144-150
|
artikel
|
| 9 |
Detection of Bladder Tumours using 18F-fluorothymidine PET-CT
|
Pearson, R.A.
|
|
2018
|
30 |
3 |
p. 197
|
artikel
|
| 10 |
Diffusion-weighted MRI for Early Response Assessment in the Treatment of Bladder Cancer
|
Pearson, R.
|
|
2018
|
30 |
3 |
p. 193
|
artikel
|
| 11 |
First Results from the ADRRAD Trial – Combination Androgen Deprivation Therapy (ADT), Whole Pelvis Radiotherapy (WPRT) and Radium 223 in Recently Diagnosed Metastatic Hormone Sensitive Prostate Cancer (MHSPCa)
|
Turner, P.G.
|
|
2018
|
30 |
3 |
p. 196
|
artikel
|
| 12 |
Metastatic Brain Disease from Non-small Cell Lung Cancer – Getting Back to the Drawing Board
|
Greystoke, A.
|
|
2018
|
30 |
3 |
p. 137-143
|
artikel
|
| 13 |
Ninety Day Mortality and Overall Survival after Radical Radiotherapy for Non-small Cell Lung Cancer
|
Prince, S.K.
|
|
2018
|
30 |
3 |
p. 199
|
artikel
|
| 14 |
Outcome of Patients with Node-positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Definitive Surgery or Radiotherapy
|
King, J.
|
|
2018
|
30 |
3 |
p. 196-197
|
artikel
|
| 15 |
Prostate Movement and Deformation in Fractionated Prostate Radiotherapy
|
Sarwar, A.
|
|
2018
|
30 |
3 |
p. 195
|
artikel
|
| 16 |
Quality of Life and Toxicity Outcomes for Patients Treated with Stereotactic Radiotherapy for Oligo-metastatic Prostate Cancer — a Single Institution Experience at Mount Vernon Cancer Centre (MVCC)
|
Smith, T.
|
|
2018
|
30 |
3 |
p. 193-194
|
artikel
|
| 17 |
Radical Bladder Treatment and Outcomes in the Northern Ireland Cancer Centre
|
Crockett, C.
|
|
2018
|
30 |
3 |
p. 193
|
artikel
|
| 18 |
Radium 223: Experience of the First 100 Patients in a Regional Centre
|
Thompson, M.K.
|
|
2018
|
30 |
3 |
p. 196
|
artikel
|
| 19 |
Radium 223 Therapy in Symptomatic Metastatic Castrate Resistant Prostate Cancer – Newcastle Experience: a Quality of Life Issue
|
Jiang, X.Y.
|
|
2018
|
30 |
3 |
p. 194
|
artikel
|
| 20 |
RCR Meetings
|
|
|
2018
|
30 |
3 |
p. I
|
artikel
|
| 21 |
Reduction in Total Radiation Exposure Using X-ray Image Guidance Illustrated in a Patient Receiving Pituitary Radiotherapy
|
Brochu, F.
|
|
2018
|
30 |
3 |
p. 199-200
|
artikel
|
| 22 |
Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer
|
Thiruthaneeswaran, N.
|
|
2018
|
30 |
3 |
p. 195-196
|
artikel
|
| 23 |
Single Fraction Stereotactic Ablative Body Radiotherapy for Oligometastasis: Outcomes from 132 Consecutive Patients
|
Gandhidasan, S.
|
|
2018
|
30 |
3 |
p. 178-184
|
artikel
|
| 24 |
The Patient Perspective on Radiogenomics Testing for Breast Radiation Toxicity
|
Rattay, T.
|
|
2018
|
30 |
3 |
p. 151-157
|
artikel
|
| 25 |
Whole Pelvis Irradiation Improves Biochemical Progression-free Survival in High-risk Prostate Cancer Patients Treated with External Beam Radiotherapy and High Dose Rate (HDR) Brachytherapy
|
Tharmalingam, H.
|
|
2018
|
30 |
3 |
p. 195
|
artikel
|
Tijdschrift beschrijving